0Suppliers
1Customers
3Debt Items
10Related Chains

Emergent BioSolutions Inc. Suppliers

No suppliers on recordEmergent BioSolutions Inc. has not yet been matched to upstream suppliers in our database, or is still being processed.

Emergent BioSolutions Inc. Customers

TickerNameConfidenceEvidence
VXRT Vaxart, Inc. 72% Reciprocal relationship from VXRT graph: irements relating to the organization of personnel, buildings and facilities, equipment, control of components and drug product containers and closures, produ…

Emergent BioSolutions Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
EBS-DEBT-9208 Xbrl Convertible 90% xbrl convertible detail from xbrl 2018-12-31.
EBS-DEBT Debt stack $584.6M 90% Market cache reports total debt of $584.6M.
EBS-DEBT-9207 Warrants outstanding: 5500000 90% xbrl warrant detail from xbrl 2025-12-31.

Emergent BioSolutions Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Emergent BioSolutions Inc..

Emergent BioSolutions Inc. Ownership

HolderNameConfidenceEvidence
EBS-OWNER-VANGUARD-CAPITAL-MANAGEMENT-LLC VANGUARD CAPITAL MANAGEMENT LLC 90% 13F overlay lists VANGUARD CAPITAL MANAGEMENT LLC as top holder; 192 tracked holders.

Emergent BioSolutions Inc. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
SNYNF Sanofi 100.00 2
BDRX Biodexa Pharmaceuticals Plc 100.00 2
VXRT Vaxart, Inc. 100.00 1 ['customer']
COCP Cocrystal Pharma, Inc. 50.00 2
SGIOF Shionogi & Co., Ltd. 50.00 2
MRK Merck & Co., Inc. 50.00 2
HCRP HCRP 50.00 2
CSLLY CSL Limited 50.00 2
FTRE Fortrea Holdings Inc. 50.00 2
SABS SAB Biotherapeutics, Inc. 36.29 1 ['spend']